SciELO - Scientific Electronic Library Online

 
vol.148 número7Actualización general de inmunoterapia en cáncerHerramientas para la interpretación de informes endoscópicos: clasificaciones y escalas en endoscopía digestiva índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

FONCEA, Camila et al. Osteonecrosis of the jaws. Rev. méd. Chile [online]. 2020, vol.148, n.7, pp.983-991. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872020000700983.

Medication-related osteonecrosis of the jaw is a disease where there is necrotic bone exposed or that can be explored by means of a fistula in the maxillofacial region. It has been associated with the use Biphosphonates and denosumab for osteoporosis. Although its etiology is unclear, it may be related to a decrease in bone turnover produced by these drugs, rendering the bone more prone to generate cell necrosis during invasive dental procedures, especially in the posterior region of the jaw. There is no consensus about the prevention and treatment of this condition. The aim of this paper is to present a review of the literature with the main characteristics of osteonecrosis of the jaws associated with drugs, together with a proposal for prevention and treatment for these patients.

Palavras-chave : Osteonecrosis; Angiogenesis Inhibitors; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates.

        · texto em Espanhol     · Espanhol ( pdf )